Glatiramer acetate

July 20, 2023

Glatiramer acetate is a synthetic protein that simulates myelin basic protein, a component of the myelin that insulates nerve fibers in the brain and spinal cord. This drug seems to block myelin-damaging T-cells through a mechanism that is not completely understood.
Glatiramer acetate injection is approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with relapsing forms of multiple sclerosis.


Status:In Mass Production
Unit:5mg,10mg,1g/customized
Capacity: 1kg/month

Request a Quick Quote

Raw Glatiramer acetate powder (147245-92-9) video

Glatiramer acetate Description

Glatiramer acetate is a synthetic protein that simulates myelin basic protein, a component of the myelin that insulates nerve fibers in the brain and spinal cord. This drug seems to block myelin-damaging T-cells through a mechanism that is not completely understood.

Glatiramer acetate injection is approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with relapsing forms of multiple sclerosis.

Glatiramer acetate Specifications

Product NameGlatiramer acetate
Chemical Name(S)-2,6-diaminohexanoic acid compound with(S)-2-amino-3-(4-hydroxyphenyl)propanoic acid and (S)-2-aminopentanedioic acid and (S)-2-aminopropanoic acid and acetic acid (1:1:1:1:1)
Brand NameCopaxone (Teva).
Drug ClassPeptide
CAS Number147245-92-9
InChIKeyFHEAIOHRHQGZPC-KIWGSFCNSA-N
Molecular FormulaC25H45N5O13
Molecular Weight623.6505
Monoisotopic Mass623.65
Melting Point N/A
Biological Half-LifeN/A
ColorWhite
Solubility <6.24mg/mL in DMSO
Storage Temperature −20°C
ApplicationGA treatment led to sustained augmentation of the expression of BDNF, NT-3, and NT-4 in various brain regions.

Contact Us

Polypeptide Peptide dosage calculator